Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.990
+0.140 (2.89%)
At close: Jul 17, 2025, 4:00 PM HKT
-38.70%
Market Cap1.19B
Revenue (ttm)56.97M
Net Income (ttm)-111.06M
Shares Out239.11M
EPS (ttm)-0.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume323,400
Average Volume92,840
Open4.890
Previous Close4.850
Day's Range4.890 - 5.230
52-Week Range3.200 - 14.020
Beta-1.14
RSI51.35
Earnings DateAug 28, 2025

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases... [Read more]

Sector Healthcare
Founded 2013
Employees 276
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6922
Full Company Profile

Financial Performance

In 2024, HKG:6922's revenue was 53.53 million, an increase of 30.72% compared to the previous year's 40.95 million. Losses were -104.37 million, 7.06% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.